EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma - Concepedia

Concepedia

Publication | Open Access

EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma

DOI Full Paper Access

29

Citations

26

References

2023

Year

Yujie Zhou, Dongdong Xiao, Xiaobing Jiang, Chuansheng Nie

Journal of Translational Medicine

Abstract

EREG is the core onco-immunological biomarker of CuAS and modulates the cross-talk between VEGF and CD99 signaling in glioblastoma, and CuAS may provide support for immunotherapy and chemotherapy.

References

	Year	Citations

Page 1